A breakthrough mRNA cancer vaccine has shown the ability to supercharge the effects of immunotherapy in mice, sparking hope for a universal “off-the-shelf” treatment that could fight multiple cancers. Unlike traditional vaccines designed to target specific tumor proteins, this approach simply revs up the immune system as if it were fighting a virus. The results were dramatic—when paired with checkpoint inhibitors, tumors shrank, and in some cases, the vaccine alone wiped them out.

Why it’s exciting: This could be the first step toward a broad, fast, and affordable anti-cancer vaccine platform—a game changer compared to today’s slow, hyper-targeted treatments.

Read more → Science Daily